SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

The FDAs Complete Response Letter for ivonescimab, citing the lack of a statistically significant overall-survival benefit, is driving the selloff and debate. Bears view the decision as a major setback, while bulls argue the broader pipelineespecially the HARMONi-3 readoutremains the key test of Summits prospects.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,112,050. The last known price of Bitcoin is 63,437.21016941 USD and is down -7.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $45,086,253,428.50 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and volatile trading have traders focused on whether support and oversold conditions will trigger a relief bounce or give way to further declines. Some blame liquidations, ETF selling and macro headwinds, while others see the drop as a buying opportunity or a potential short squeeze.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,752,062,860.16806072. The last known price of Dogecoin is 0.05689686 USD and is down -11.89 over the last 24 hours. It is currently trading on 1545 active market(s) with $1,128,721,930.78 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a broad crypto selloff and a steep decline that traders describe as pushing it toward multiyear lows. The conversation is split between holders calling the weakness a buying opportunity and bears warning of further losses, with many questioning whether DOGE can regain momentum.

JasmyCoin (JASMY) is a cryptocurrency launched in 2016and operates on the Ethereum platform. JasmyCoin has a current supply of 50,000,000,000 with 49,444,999,677.16957912 in circulation. The last known price of JasmyCoin is 0.00312867 USD and is down -5.82 over the last 24 hours. It is currently trading on 374 active market(s) with $10,034,947.48 traded over the last 24 hours. More information can be found at https://www.jasmy.co.jp/en_company.html.

JasmyCoin

JASMYs weak, volatile price action is driving a split between holders buying the dip and critics frustrated by its prolonged underperformance, limited on-chain activity, and the teams focus on Janction. Bulls point to the AppBank/Money Twin collaboration and JasmyChains potential utility, but debate centers on whether those developments will translate into real adoption.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Anticipation of Phase 3 APPROACH topline results for HLP003 in adjunctive major depressive disorder is dominating discussion, with traders treating the readout as a high-stakes catalyst and highlighting the trials add-on design. Optimism about efficacy and Heluss potential advantages is tempered by uncertainty around the results, dilution, and the risk of a disappointing readout.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depots upcoming quarterly report is drawing attention, with traders focused on comparable sales, customer traffic, margins and any guidance changes. Some expect the recent rally to continue, while others see weak housing and renovation demand, high rates and reliance on tariff refunds as risks to the outlook.

Autonomi (ANT) is a cryptocurrency launched in 2025and operates on the Arbitrum platform. Autonomi has a current supply of 1,200,000,000 with 346,331,579 in circulation. The last known price of Autonomi is 0.03106712 USD and is down -0.55 over the last 24 hours. It is currently trading on 15 active market(s) with $122,300.99 traded over the last 24 hours. More information can be found at https://autonomi.com.

Aragon

Most of the attention appears to come from confusion between Aragons $ANT.X ticker and Anthropics planned IPO, with traders debating the IPOs valuation and potential effect on tech and crypto markets. Aragon-specific posts instead discuss its DAO governance tools and its completed token redemption initiative; no clear new catalyst for the Aragon token dominates.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation amid scrutiny over alleged chip diversions to China and export-control compliance dominates discussion, with traders debating whether he could return as CEO and whether the allegations threaten Nvidias leadership or business. Some see the comeback talk as a potential positive, while others consider a return unlikely and focus on regulatory and governance risks ahead of earnings.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZenecas quarterly results beat expectations, alongside a cost-savings plan to redirect resources toward drug development, have reinforced the companys growth and pipeline narrative. Traders are also discussing its oncology collaborations and potential acquisitions, though enthusiasm is tempered by concerns about trial setbacks and whether pipeline prospects are reflected in the stock.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

A nationwide FAA ground stop following air-traffic-control communications failures has disrupted flights and pressured airline shares, including Delta. Traders debate whether the cancellations will be a temporary operational hit or weigh on results, while speculation about the outages cause remains unverified; officials have said the root cause is under investigation.

statis crypto Watchlist

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
